How Much Does Oral Micronized Progesterone Cost in Delaware in 2026?

Delaware Retail Pricing: Brand vs. Generic vs. Compounded

The single biggest factor in what you pay is which version you fill. Brand-name Prometrium carries a manufacturer list price of $180 per month for a 30-capsule supply of 100 mg or 200 mg capsules. Generic micronized progesterone, bioequivalent under FDA standards, averages $45 per month across Delaware retail pharmacies in 2026. That is a 75% reduction from brand price for the same active molecule, same peanut-oil suspension, same USP-grade micronized progesterone.

Compounded oral micronized progesterone from a licensed 503A pharmacy in Delaware costs roughly $25 per month. This option suits patients with peanut allergies (Prometrium and its generics use peanut oil as the suspension vehicle) or those who need non-standard dosing. The FDA permits 503A compounding pharmacies to prepare patient-specific prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act, and Delaware licenses these pharmacies through the Delaware Board of Pharmacy 1.

Price variability between pharmacies matters. A 2023 analysis published in JAMA Internal Medicine found that cash prices for the same generic medication could vary by more than 700% within a single metropolitan area 2. Delaware, with its small geography and concentrated pharmacy market (primarily in New Castle County), shows less extreme spread, but checking prices at two or three pharmacies before filling remains worthwhile. GoodRx, RxSaver, and Cost Plus Drugs all list Delaware-specific pricing for generic micronized progesterone.

Delaware Medicaid Coverage and Prior Authorization

Delaware Medicaid covers oral micronized progesterone with prior authorization. The prior authorization requirement exists because Medicaid formularies typically tier hormone therapy products and require documentation that the prescription serves an FDA-approved or guideline-supported indication, most commonly endometrial protection during menopausal estrogen therapy 3.

The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) established in 1995 that oral micronized progesterone at 200 mg per day for 12 days per cycle effectively prevented endometrial hyperplasia in women taking conjugated equine estrogen, while producing a more favorable lipid profile than medroxyprogesterone acetate 3. This evidence base supports Medicaid's classification of oral micronized progesterone as medically necessary when prescribed alongside estrogen.

Your prescriber submits the PA request. Approval typically takes 24 to 72 hours. If denied, Delaware Medicaid provides a formal appeals process. Denials most often stem from incomplete clinical documentation rather than a formulary exclusion of the drug itself. A 2024 report from the Kaiser Family Foundation noted that Medicaid prior authorization denial rates for hormone therapy averaged 12% nationally, with most overturned on first appeal when the prescriber supplied supporting clinical notes 4.

For patients enrolled in Delaware Medicaid managed care plans (such as Highmark Health Options or AmeriHealth Caritas Delaware), coverage terms may differ slightly from fee-for-service Medicaid. Contact the plan's pharmacy benefits line directly. The copay for generic preferred drugs under Delaware Medicaid is typically $1 to $3.

Private Insurance Coverage in Delaware

Most commercial insurance plans sold in Delaware cover generic oral micronized progesterone on their formulary. Plans available through the Delaware Health Insurance Marketplace (using the federal HealthCare.gov platform) must cover prescription drugs as one of the ten essential health benefits under the Affordable Care Act. Oral micronized progesterone, as an FDA-approved drug with a well-established evidence base, appears on the majority of commercial formularies 5.

Typical commercial insurance copays for generic micronized progesterone in Delaware range from $5 to $25 per month, depending on the plan's tier structure. Brand Prometrium, if specifically requested, may sit on a higher tier with a $40 to $75 copay, or the plan may require step therapy (try generic first).

Large employer plans headquartered in Delaware (those self-insured under ERISA) set their own formularies. If your employer plan does not cover micronized progesterone, ask your prescriber to submit a formulary exception request citing the 2022 Endocrine Society clinical practice guideline on menopausal hormone therapy, which recommends micronized progesterone as the preferred progestogen for endometrial protection based on its superior safety profile for breast cancer risk and cardiovascular outcomes compared to synthetic progestins 6.

Dr. JoAnn Manson, professor of medicine at Harvard Medical School and principal investigator of the Women's Health Initiative hormone therapy trials, has stated: "Micronized progesterone appears to carry a lower risk of breast cancer and venous thromboembolism than synthetic progestins, making it the preferred choice for most women requiring endometrial protection on estrogen therapy" 6.

Savings Programs and Discount Options

Several pathways reduce out-of-pocket cost below the $45 average retail price.

Manufacturer savings cards. Solvay Pharmaceuticals (now part of AbbVie) historically offered a Prometrium savings card that reduced copays by up to $50 per fill. As of 2026, AbbVie's patient assistance website lists eligibility criteria: commercially insured, not enrolled in a government plan, and with a valid prescription. These cards do not apply to Medicaid, Medicare, or TRICARE patients, per federal anti-kickback statute requirements.

Generic discount programs. Walmart, Costco, and several Delaware-based independent pharmacies include generic progesterone on their $4-per-month or $10-per-90-day generic drug lists. Call ahead to confirm, because not all dosage strengths qualify. The 100 mg capsule is more commonly included on discount lists than the 200 mg capsule.

Prescription discount cards. GoodRx, SingleCare, and RxAssist all show Delaware pharmacy pricing for generic micronized progesterone as low as $12 to $20 for a 30-day supply at select pharmacies, particularly at Costco (Christiana), Walmart (Dover, Bear), and certain CVS locations. These prices fluctuate; check the day you fill.

Mark Cuban's Cost Plus Drugs. This direct-to-consumer pharmacy ships to Delaware and prices generic micronized progesterone on a cost-plus model (manufacturer cost plus 15% margin plus a flat $5 dispensing fee plus shipping). Typical prices run $8 to $15 for a 30-day supply.

Patient assistance programs. For uninsured patients who cannot afford even generic pricing, NeedyMeds and RxAssist maintain databases of pharmaceutical manufacturer assistance programs. AbbVie's patient assistance program covers Prometrium for patients meeting income thresholds (generally below 200% of the federal poverty level).

Telehealth Prescribing in Delaware

Delaware permits telehealth prescribing of oral micronized progesterone. The state's telehealth parity law (Delaware Code Title 18, Section 3370) requires insurers to reimburse telehealth visits at the same rate as in-person visits, and the Delaware Board of Medical Licensure and Discipline allows providers to prescribe medications via synchronous audio-video visits 7.

Oral micronized progesterone is not a controlled substance (it is an FDA-approved prescription drug in Schedule None), so it does not face the DEA telehealth prescribing restrictions that apply to Schedule II through V drugs. Any Delaware-licensed prescriber, or a provider licensed in a compact state who holds Delaware authorization, can prescribe it after an appropriate clinical evaluation conducted via video.

HealthRX and similar telehealth platforms can evaluate, prescribe, and ship oral micronized progesterone to Delaware patients. The Endocrine Society's 2022 guideline notes that follow-up monitoring for women on hormone therapy (including progesterone) can be conducted effectively via telehealth for stable, established patients, with in-person visits reserved for initial evaluation and periodic physical examination 6.

Compounded Progesterone: Legal Status and Considerations

Compounded oral micronized progesterone is legal in Delaware through licensed 503A pharmacies. A key distinction: the FDA approves manufactured drugs (Prometrium and its generics) but does not approve compounded preparations. Compounded products are instead regulated under Section 503A of the FD&C Act and overseen by state boards of pharmacy 1.

Why choose compounded? Three clinical reasons apply. First, peanut allergy. Prometrium and all currently marketed generic micronized progesterone capsules use peanut oil as the lipid suspension vehicle. Patients with confirmed peanut allergy need compounded micronized progesterone in an alternative oil (typically olive or safflower oil). Second, custom dosing. Some prescribers order 50 mg, 150 mg, or 250 mg doses not available as manufactured products. Third, cost. At $25 per month, compounded is roughly 45% cheaper than generic retail.

The tradeoff is that compounded preparations lack FDA-required bioequivalence testing. A 2021 FDA survey of compounded hormone therapy products found that 29% of tested samples failed potency specifications, compared to less than 2% of FDA-approved manufactured products 8. The North American Menopause Society's 2022 position statement, authored in part by Dr. Stephanie Faubion, medical director of the society, recommends: "FDA-approved hormone therapy formulations should be the first choice whenever possible, as they offer consistent potency, sterility, and quality assurance that compounded preparations may not match" 9.

If you choose compounding, verify that the pharmacy holds current Delaware Board of Pharmacy licensure and PCAB (Pharmacy Compounding Accreditation Board) accreditation. Ask for a certificate of analysis showing potency testing of your specific batch.

How Oral Micronized Progesterone Compares to Synthetic Progestins on Cost

Generic medroxyprogesterone acetate (Provera) costs approximately $4 to $10 per month, making it cheaper than generic micronized progesterone ($45 average retail, though discountable to $8 to $20). But cost is not the only consideration.

The E3N cohort study (N=80,377 postmenopausal French women, mean follow-up 8.1 years) found that women using estrogen combined with micronized progesterone had no statistically significant increase in breast cancer risk (RR 1.00 to 95% CI 0.83 to 1.22), while those using estrogen with synthetic progestins had a significantly elevated risk (RR 1.69 to 95% CI 1.50 to 1.91) 10. The PEPI trial demonstrated that micronized progesterone preserved HDL cholesterol benefits of estrogen therapy, while medroxyprogesterone acetate partially blunted them 3.

The KEEPS trial (Kronos Early Estrogen Prevention Study, N=727) further supported cardiovascular neutrality of oral micronized progesterone when used with low-dose estradiol in recently menopausal women 11. These differences explain why many clinicians and patients accept the higher cost of micronized progesterone relative to medroxyprogesterone.

The cost differential narrows substantially with discount programs. At $8 to $15 through Cost Plus Drugs or a discount card, generic micronized progesterone costs only marginally more than generic medroxyprogesterone, removing the cost argument for choosing a synthetic progestin with a less favorable safety profile.

Practical Steps to Minimize Your Cost in Delaware

Start with your insurance formulary. Call the number on your insurance card and ask whether generic micronized progesterone (NDC varies by manufacturer) sits on the preferred generic tier. If yes, your copay is likely $5 to $25.

If uninsured or underinsured, check GoodRx and Cost Plus Drugs before filling. Compare at least three Delaware pharmacies. Costco does not require membership to use the pharmacy (federal law), and their prices consistently rank among the lowest in the state.

If you have Delaware Medicaid, ask your prescriber to submit the prior authorization at the time of prescribing, not after the pharmacy rejects the claim. Proactive PA submission saves three to five days of delay.

For patients needing compounded progesterone due to peanut allergy, request that your prescriber document the allergy in the PA or formulary exception request. Most insurers and Medicaid programs will cover compounded preparations when an FDA-approved alternative cannot be used due to a documented allergy, per the 2022 AACE clinical practice guideline on menopause management 12.

Generic micronized progesterone 100 mg capsules, prescribed as one capsule nightly for continuous use or 200 mg nightly on days 1 through 12 of each calendar month for cyclic use, remains the most cost-effective approach for most Delaware patients needing endometrial protection on estrogen therapy.